A Phase III, Multicentre, Randomized, double-Blind, Placebo Controlled study to Evaluate the Efficacy, Immunogenicity and Safety of Single dose of Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophillized) – "DengiAll" of Panacea Biotec Limited in Healthy Indian Adults" under NHRP (Vector borne component) 2026 — Admit card & exam dates
1 notice from the recruiter: admit card, exam dates and document-verification calls. Every link opens the official document.
We never fill forms or hold logins — downloads happen on the recruiter's own site.